Annovis Bio, Inc. (ANVS) Misses Q3 EPS by 46c

Annovis Bio, Inc. (NYSE: ANVS) reported Q3 EPS of ($0.97), $0.46 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.

You May Also Be Interested In

• Subaru, other Japan suppliers to team on delivery as Boeing raises output - Nikkei
• Ciena beats estimates on strong AI-driven demand, shares rise
• Victoria's Secret & Co. (VSXY) Tops Q2 EPS by 20c ; Offers Guidance